IPC Current Affairs - 2019
Category Wise PDF Compilations available at This Link
Three Indians Menaka Guruswamy, Arundhati Katju and Mukesh Ambani have featured into TIME 100 Most Influential People list of 2019. Global prominent names that have featured in this list included US President Donald Trump, China President Xi Jinping, Pakistan Prime Minister Imran Khan, Pope Francis, golfer Tiger Woods and Facebook founder Mark Zuckerberg.
Mukesh Ambani: He is Chairman and largest shareholder of Reliance Industries Limited (RIL), a Fortune Global 500 company. It is most valuable Indian company in terms of its market value.
Menaka Guruswamy and Arundhati Katju: They are Indian women lawyers who lead the legal battle to strike down colonial era’s Section 377 of Indian Penal Code (IPC), which criminalized gay sex. In September 2018, Supreme Court in unanimous decision partly struck down IPC Section 377, thus removing ban imposed on consensual gay sex and affirming human rights of LGBTQ (lesbian, gay, bisexual, transgender, queer) community.
Time 100 most influential list
It is list of 100 most influential people in world released annually by US-based ‘Time’ news magazine. It was first published in 1999. Its entrants are recognized for changing world, regardless of consequences of their actions. The list has now become highly publicized event, as appearance on list is seen as global honor.
Tags: Arundhati Katju • IPC • LGBTQ • Menaka Guruswamy • Mukesh Amban
After the alerts from the Pharmacovigilance Programme of India (PvPI) the Central Drugs Standard Control Organisation (CDSCO) has asked manufacturers of 7 common antibiotics to ensure that information related to symptoms/side effects is made available to the general public.
- CDSCO has asked drug manufacturers, to mention in leaflets inserted into drug packets or on promotional literature, information about the adverse reactions of these medicines.
- Manufacturers of antibiotics Cefotaxime, Ofloxacin and Cefixime; Tranexamic Acid ( used to control bleeding) antipsychotic drug Quetiapine; anti-rheumatoid drug Sulfasalazine and the anti-epileptic medicine Sodium Valproate are instructed to warn patients of the “new” side effects.
Pharmacovigilance Programme of India
Pharmacovigilance Program of India (PvPI) was launched in 2010 with a broad objective to safeguard the health of 1.27 billion people of India. Adverse drug Reactions (ADRs) are reported from all over the country to the National Coordination centre of PvPI, which also work in collaboration with the global ADR monitoring centre (WHO-UMC), Sweden to contribute in the global ADRs database.
The Indian Pharmacopoeia Commission (IPC), Ghaziabad, (U.P.) hosts the coordination centre for PvPI. The mission of PvPI is to safeguard the health of the Indian population by ensuring that the benefit of the use of medicine outweighs the risks associated with its use.